ID: h-9192d8f97e
Hypothesis

PD genetic aging variants accelerating cell-type-specific epigenetic clock trajectories as proximal driver in Genetic Aging Landscape Variants and Epigenetic Aging in PD Neuronal Subtypes

PD genetic aging variants accelerating cell-type-specific epigenetic clock trajectories should produce a measurable proximal phenotype before late disease pathology.
🧬 PD-🩺 neurodegeneration🎯 Composite 63%💱 $0.56▼10.2%proposed
EvidencePending (0%)📖 6 cit🗣 1 debates 6 support 1 oppose
✓ All Quality Gates Passed

🧪 Overview

PD genetic aging variants accelerating cell-type-specific epigenetic clock trajectories should produce a measurable proximal phenotype before late disease pathology. The decisive test is single-nucleus multi-omic clock estimation across dopaminergic, GABAergic, and cholinergic neurons with genotype-aware models.

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["PD Genetic Aging Variants<br/>SNP Enrichment in Aging Genes"]
    B["Cell-Type-Specific Epigenetic Clock<br/>DNA Methylation Acceleration"]
    C["H3K27ac and H3K4me3 Redistribution<br/>Neuronal Subtype Vulnerability"]
    D["Transcriptomic Aging Signatures<br/>Upregulated senescence pathways"]
    E["Proteostasis Network Disruption<br/>Aggregation-Prone Protein Accumulation"]
    F["PD Onset Earlier<br/>Accelerated Neuronal Loss"]
    A --> B
    B --> C
    C --> D
    D --> E
    E --> F
    style A fill:#4a148c,stroke:#ce93d8,color:#ce93d8
    style F fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

⚖️ Evidence

⚖️ Evidence Matrix6 supports1 contradicts
Supports
Genetic aging landscape analysis identified PD-specific aging signatures but single-cell resolution of epigenetic aging in neuronal subtypes was not resolved.
Multi-omics analysis reveals the genetic aging lan
Supports
Combination strategies with PD-1/PD-L1 blockade: current advances and future directions.
Mol Cancer2022PMID:35062949medium
Supports
Regulation of PD-L1 expression in the tumor microenvironment.
J Hematol Oncol2021PMID:33413496medium
Supports
PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations.
Hum Vaccin Immunother2019PMID:30888929medium
Supports
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression.
Cell Rep2017PMID:28494868medium
Supports
A snapshot of the PD-1/PD-L1 pathway.
J Cancer2021PMID:33854633medium
Contradicts
post-mortem interval, survival bias, and disease duration can mimic accelerated epigenetic aging
Multi-omics analysis reveals the genetic aging lan
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — PD-

No curated PDB or AlphaFold mapping for PD- yet. Search RCSB →

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for PD- →

No DepMap CRISPR Chronos data found for PD-.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▼ 0.5%
Volatility
Low
0.0018
Events (7d)
2
Price History
▼10.2%

💾 Resource Usage

No resource usage or linked notebooks recorded for this hypothesis yet.

Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
sourcev1_phase_c_backfill
origin_typedebate_synthesizer
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.